SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-242573
Filing Date
2007-11-09
Accepted
2007-11-09 16:48:49
Documents
10
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 822689
2 FOURTH AMENDMENT TO THE AMGEN SUPPLEMENTAL RETIREMENT PLAN dex1013.htm EX-10.13 11273
3 FIRST AMENDMENT TO THE AMGEN INC. EXECUTIVE NONQUALIFIED RETIREMENT PLAN dex1026.htm EX-10.26 12110
4 FOURTH AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN dex1031.htm EX-10.31 14590
5 AMENDMENT TO PROMISSORY NOTE dex1041.htm EX-10.41 2987
6 COLLABORATION AGREEMENT dex1080.htm EX-10.80 417855
7 SECTION 302 CEO AND CFO CERTIFICATION dex31.htm EX-31 20650
8 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 9392
9 GRAPHIC g36996img001.jpg GRAPHIC 4682
10 GRAPHIC g36996img002.jpg GRAPHIC 3870
  Complete submission text file 0001193125-07-242573.txt   1325152
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 071232416
SIC: 2836 Biological Products, (No Diagnostic Substances)